SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-K’ for 12/31/12 – ‘EX-101.CAL’

On:  Friday, 3/15/13, at 4:50pm ET   ·   For:  12/31/12   ·   Accession #:  1193125-13-110112   ·   File #:  0-19627

Previous ‘10-K’:  ‘10-K/A’ on 7/6/12 for 12/31/11   ·   Next:  ‘10-K’ on 3/17/14 for 12/31/13   ·   Latest:  ‘10-K’ on 3/21/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/15/13  Biolase, Inc                      10-K       12/31/12   76:8.5M                                   Donnelley … Solutions/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.11M 
 2: EX-21.1     Subsidiaries List                                   HTML     20K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
52: R1          Document and Entity Information                     HTML     53K 
41: R2          Consolidated Balance sheets                         HTML    144K 
50: R3          Consolidated Balance sheets (Parenthetical)         HTML     51K 
54: R4          Consolidated Statements of Operations and           HTML    121K 
                Comprehensive Loss                                               
70: R5          Consolidated Statements of Shareholders' Equity     HTML     97K 
                (Deficit)                                                        
43: R6          Consolidated Statements of Cash Flows               HTML    180K 
49: R7          Basis Of Presentation                               HTML     42K 
37: R8          Summary Of Significant Accounting Policies          HTML     97K 
28: R9          Supplementary Balance Sheet Information             HTML     67K 
71: R10         Intangible Assets And Goodwill                      HTML     52K 
56: R11         Lines Of Credit And Other Borrowings                HTML     36K 
55: R12         Income Taxes                                        HTML     87K 
61: R13         Commitments And Contingencies                       HTML     38K 
62: R14         Stockholders' Equity                                HTML    108K 
59: R15         Segment Information                                 HTML     37K 
63: R16         Concentrations                                      HTML     25K 
51: R17         Non-Recurring Event                                 HTML     25K 
53: R18         Subsequent Events                                   HTML     23K 
58: R19         Schedule II-Consolidated Valuation and Qualifying   HTML     41K 
                Accounts and Reserves                                            
76: R20         Basis Of Presentation (Policies)                    HTML    242K 
66: R21         Summary Of Significant Accounting Policies          HTML     59K 
                (Tables)                                                         
46: R22         Supplementary Balance Sheet Information (Tables)    HTML     72K 
57: R23         Intangible Assets And Goodwill (Tables)             HTML     43K 
48: R24         Income Taxes (Tables)                               HTML     84K 
22: R25         Commitments And Contingencies (Tables)              HTML     26K 
67: R26         Stockholders' Equity (Tables)                       HTML     83K 
73: R27         Segment Information (Tables)                        HTML     30K 
32: R28         Schedule II-Consolidated Valuation and Qualifying   HTML     39K 
                Accounts and Reserves (Tables)                                   
31: R29         Basis of Presentation - Additional Information      HTML     55K 
                (Detail)                                                         
35: R30         Estimated Useful Lives Of Property, Plant and       HTML     28K 
                Equipment (Detail)                                               
36: R31         Summary of Significant Accounting Policies -        HTML     98K 
                Additional Information (Detail)                                  
38: R32         Accrued Liabilities - Changes In Initial Product    HTML     41K 
                Warranty Accrual and Expenses Under Initial and                  
                Extended Warranties (Detail)                                     
20: R33         Classification Of Compensation Expense Associated   HTML     32K 
                With Share-Based Payments (Detail)                               
64: R34         Assumptions Used in Estimating Fair Value Of Stock  HTML     34K 
                Options Granted (Detail)                                         
45: R35         Components of Accounts Receivable, Net of           HTML     30K 
                Allowance (Detail)                                               
47: R36         Supplementary Balance Sheet Information -           HTML     52K 
                Additional Information (Detail)                                  
25: R37         Components of Inventory (Detail)                    HTML     34K 
75: R38         Summary of Property,Plant and Equipment (Detail)    HTML     39K 
14: R39         Components of Accrued Liabilities (Detail)          HTML     50K 
39: R40         Summary of Deferred Revenue (Detail)                HTML     40K 
69: R41         Intangible Assets And Goodwill - Additional         HTML     47K 
                Information (Detail)                                             
24: R42         Intangible Assets Related to Accumulated            HTML     54K 
                Amortization and Goodwill (Detail)                               
30: R43         Lines Of Credit And Other Borrowings - Additional   HTML    128K 
                Information (Detail)                                             
34: R44         Summary of Income Tax Current and Deferred          HTML     65K 
                Provision (Benefit) (Detail)                                     
42: R45         Federal Income Tax Provision Compared With          HTML     63K 
                Statutory Rates (Detail)                                         
19: R46         Summary of Net Deferred Tax Assets and Net          HTML     83K 
                Deferred Tax Liabilities (Detail)                                
27: R47         Income Taxes - Additional Information (Detail)      HTML     61K 
16: R48         Summary of Unrecognized Tax Benefits (Detail)       HTML     31K 
68: R49         Commitments And Contingencies - Additional          HTML     38K 
                Information (Detail)                                             
23: R50         Future Minimum Rental Commitments Under Operating   HTML     45K 
                Lease Agreements (Detail)                                        
65: R51         Stockholders' Equity - Additional Information       HTML    163K 
                (Detail)                                                         
26: R52         Summary of Option Activity (Detail)                 HTML     83K 
40: R53         Options Outstanding and Exercisable (Detail)        HTML     70K 
15: R54         Cash Proceeds Along With Fair Value Disclosures     HTML     41K 
                Related to grants Exercises And Vesting Options                  
                (Detail)                                                         
17: R55         Segment Information - Additional Information        HTML     32K 
                (Detail)                                                         
33: R56         Summary of Net Revenue by Geographic Location       HTML     27K 
                (Detail)                                                         
21: R57         Concentrations - Additional Information (Detail)    HTML     36K 
72: R58         Non Recurring Event - Additional Information        HTML     36K 
                (Detail)                                                         
44: R59         Subsequent Events - Additional Information          HTML     30K 
                (Detail)                                                         
60: R60         Consolidated Valuation and Qualifying Accounts and  HTML     36K 
                Reserves (Detail)                                                
74: XML         IDEA XML File -- Filing Summary                      XML    115K 
29: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.02M 
 8: EX-101.INS  XBRL Instance -- biol-20121231                       XML   1.69M 
10: EX-101.CAL  XBRL Calculations -- biol-20121231_cal               XML    251K 
11: EX-101.DEF  XBRL Definitions -- biol-20121231_def                XML   1.09M 
12: EX-101.LAB  XBRL Labels -- biol-20121231_lab                     XML   1.77M 
13: EX-101.PRE  XBRL Presentations -- biol-20121231_pre              XML   1.22M 
 9: EX-101.SCH  XBRL Schema -- biol-20121231                         XSD    255K 
18: ZIP         XBRL Zipped Folder -- 0001193125-13-110112-xbrl      Zip    218K 


‘EX-101.CAL’   —   XBRL Calculations — biol-20121231_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- RR Donnelley Xcelerate Taxonomy Calculation Linkbase, based on XBRL 2.1 http://www.edgar-online.com/ -->
<!-- Version: 6.20.1 -->
<!-- Round: 4 -->
<!-- Creation date: 2013-03-15T19:21:09Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DocumentDocumentandEntityInformation" roleURI="http://www.biolase.com/taxonomy/role/DocumentDocumentandEntityInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_StatementOfIncome" roleURI="http://www.biolase.com/taxonomy/role/StatementOfIncome"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://www.biolase.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://www.biolase.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureBasisOfPresentationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureEstimatedUsefulLivesOfPropertyPlantAndEquipment" roleURI="http://www.biolase.com/taxonomy/role/DisclosureEstimatedUsefulLivesOfPropertyPlantAndEquipment"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureAccruedLiabilitiesChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties" roleURI="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPayments" roleURI="http://www.biolase.com/taxonomy/role/DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPayments"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted" roleURI="http://www.biolase.com/taxonomy/role/DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureComponentsOfAccountsReceivableNetOfAllowance" roleURI="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccountsReceivableNetOfAllowance"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSupplementaryBalanceSheetInformationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSupplementaryBalanceSheetInformationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureComponentsOfInventory" roleURI="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfInventory"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfPropertyPlantAndEquipment" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfPropertyPlantAndEquipment"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureComponentsOfAccruedLiabilities" roleURI="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccruedLiabilities"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfDeferredRevenue" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfDeferredRevenue"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureIntangibleAssetsAndGoodwillAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureIntangibleAssetsRelatedToAccumulatedAmortizationAndGoodwill" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsRelatedToAccumulatedAmortizationAndGoodwill"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfIncomeTaxCurrentAndDeferredProvisionBenefit" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfIncomeTaxCurrentAndDeferredProvisionBenefit"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureFederalIncomeTaxProvisionComparedWithStatutoryRates" roleURI="http://www.biolase.com/taxonomy/role/DisclosureFederalIncomeTaxProvisionComparedWithStatutoryRates"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfNetDeferredTaxAssetsAndNetDeferredTaxLiabilities" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetDeferredTaxAssetsAndNetDeferredTaxLiabilities"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureIncomeTaxesAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfUnrecognizedTaxBenefits" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfUnrecognizedTaxBenefits"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureFutureMinimumRentalCommitmentsUnderOperatingLeaseAgreements" roleURI="http://www.biolase.com/taxonomy/role/DisclosureFutureMinimumRentalCommitmentsUnderOperatingLeaseAgreements"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureStockholdersEquityAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfOptionActivity" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfOptionActivity"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureOptionsOutstandingAndExercisable" roleURI="http://www.biolase.com/taxonomy/role/DisclosureOptionsOutstandingAndExercisable"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions" roleURI="http://www.biolase.com/taxonomy/role/DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSegmentInformationAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSummaryOfNetRevenueByGeographicLocation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetRevenueByGeographicLocation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureConcentrationsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureConcentrationsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureNonRecurringEventAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureNonRecurringEventAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureSubsequentEventsAdditionalInformation" roleURI="http://www.biolase.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#DisclosureConsolidatedValuationAndQualifyingAccountsAndReserves" roleURI="http://www.biolase.com/taxonomy/role/DisclosureConsolidatedValuationAndQualifyingAccountsAndReserves"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsSegmentReportingDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsConcentrationsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsConcentrationsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsNonRecurringEvents" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsNonRecurringEvents"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
<roleRef xlink:type="simple" xlink:href="biol-20121231.xsd#Role_NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockTables" roleURI="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockTables"/>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DocumentDocumentandEntityInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassified">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CustomerDepositsCurrent" xlink:label="us-gaap_CustomerDepositsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="us-gaap_DeferredTaxAssetsNetNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_StockholdersEquityExcludingTreasuryStock" xlink:label="biol_StockholdersEquityExcludingTreasuryStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredTaxAssetsNetNoncurrent" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1.1800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.1900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1.2000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1.2800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LinesOfCreditCurrent" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_CustomerDepositsCurrent" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="1.1500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="biol_StockholdersEquityExcludingTreasuryStock" order="1.2600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_TreasuryStockValue" order="1.2700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_PreferredStockValue" order="1.2100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_CommonStockValue" order="1.2200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.2300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1.2400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_StockholdersEquityExcludingTreasuryStock" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.2500" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfIncome">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_CostOfRevenuePriorToNonrecurringEvent" xlink:label="biol_CostOfRevenuePriorToNonrecurringEvent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_LicenseFeesAndRoyaltyRevenue" xlink:label="biol_LicenseFeesAndRoyaltyRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_NonRecurringCostOfRevenue" xlink:label="biol_NonRecurringCostOfRevenue"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_NonRecurringRevenue" xlink:label="biol_NonRecurringRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_ProductsAndServicesRevenue" xlink:label="biol_ProductsAndServicesRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostOfRevenue" xlink:to="biol_CostOfRevenuePriorToNonrecurringEvent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostOfRevenue" xlink:to="biol_NonRecurringCostOfRevenue" order="1.0600" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_SalesRevenueNet" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="1.0700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1.1800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1.1900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.2000" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.1500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.1600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="1.1700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1.1200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1.1300" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_ProductsAndServicesRevenue" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_NonRecurringRevenue" order="1.0200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_SalesRevenueNet" xlink:to="biol_LicenseFeesAndRoyaltyRevenue" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/StatementOfCashFlowsIndirect">
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_AmortizationOfDiscountsOnLinesOfCredit" xlink:label="biol_AmortizationOfDiscountsOnLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerDeposits" xlink:label="us-gaap_IncreaseDecreaseInCustomerDeposits"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_OtherEquityInstrumentsCompensation" xlink:label="biol_OtherEquityInstrumentsCompensation"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsForRepurchaseOfWarrants" xlink:label="us-gaap_PaymentsForRepurchaseOfWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_PaymentsOfStockRepurchaseCosts" xlink:label="biol_PaymentsOfStockRepurchaseCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_ProceedsFromSaleOfCommonStockNetOfIssuanceCosts" xlink:label="biol_ProceedsFromSaleOfCommonStockNetOfIssuanceCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.2100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1.2500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="1.3600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="1.3700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1.2600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="1.2700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="1.2800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="1.2900" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="1.3000" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1.3100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfWarrants" order="1.3200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="biol_ProceedsFromSaleOfCommonStockNetOfIssuanceCosts" order="1.3300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="biol_PaymentsOfStockRepurchaseCosts" order="1.3400" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1.3500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.2200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets" order="1.2300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1.2400" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="1.0300" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AssetImpairmentCharges" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="biol_AmortizationOfDiscountsOnLinesOfCredit" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="biol_OtherEquityInstrumentsCompensation" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="1.1200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1.1300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="1.1500" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.1600" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.1700" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInCustomerDeposits" order="1.1800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="1.1900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="1.2000" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureEstimatedUsefulLivesOfPropertyPlantAndEquipment"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureAccruedLiabilitiesChangesInInitialProductWarrantyAccrualAndExpensesUnderInitialAndExtendedWarranties"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureClassificationOfCompensationExpenseAssociatedWithShareBasedPayments"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureAssumptionsUsedInEstimatingFairValueOfStockOptionsGranted"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccountsReceivableNetOfAllowance">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_RoyaltiesReceivables" xlink:label="biol_RoyaltiesReceivables"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_TradeAccountReceivable" xlink:label="biol_TradeAccountReceivable"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="biol_TradeAccountReceivable" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="biol_RoyaltiesReceivables" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSupplementaryBalanceSheetInformationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfInventory">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterials" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcess" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfPropertyPlantAndEquipment">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0200" weight="-1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureComponentsOfAccruedLiabilities">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="us-gaap_AccruedInsuranceCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_AccruedSupportServices" xlink:label="biol_AccruedSupportServices"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StandardProductWarrantyAccrualCurrent" xlink:label="us-gaap_StandardProductWarrantyAccrualCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_StandardProductWarrantyAccrualCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="biol_AccruedSupportServices" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="1.0700" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfDeferredRevenue">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_UndeliveredElementsExtendedWarrantyCurrent" xlink:label="biol_UndeliveredElementsExtendedWarrantyCurrent"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_UndeliveredElementsExtendedWarrantyNoncurrent" xlink:label="biol_UndeliveredElementsExtendedWarrantyNoncurrent"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices" xlink:label="biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenue" xlink:to="biol_UndeliveredElementsTrainingInstallationAndProductAndSupportServices" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenue" xlink:to="biol_UndeliveredElementsExtendedWarrantyCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenue" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="biol_UndeliveredElementsExtendedWarrantyNoncurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIntangibleAssetsRelatedToAccumulatedAmortizationAndGoodwill">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_FiniteLivedIntangibleAssetsImpairment" xlink:label="biol_FiniteLivedIntangibleAssetsImpairment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0200" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="biol_FiniteLivedIntangibleAssetsImpairment" order="1.0300" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureLinesOfCreditAndOtherBorrowingsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfIncomeTaxCurrentAndDeferredProvisionBenefit">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_TotalDeferredIncomeTaxExpenseBenefit" xlink:label="biol_TotalDeferredIncomeTaxExpenseBenefit"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="biol_TotalDeferredIncomeTaxExpenseBenefit" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_TotalDeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_TotalDeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="biol_TotalDeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="1.0700" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureFederalIncomeTaxProvisionComparedWithStatutoryRates">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_EffectiveIncomeTaxRateReconciliationOtherReconcilingItems" xlink:label="biol_EffectiveIncomeTaxRateReconciliationOtherReconcilingItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="biol_EffectiveIncomeTaxRateReconciliationOtherReconcilingItems" order="1.1100" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetDeferredTaxAssetsAndNetDeferredTaxLiabilities">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" xlink:label="us-gaap_DeferredTaxAssetsOtherComprehensiveLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes" xlink:label="us-gaap_DeferredTaxAssetsStateTaxes"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_DeferredTaxAssetsUnrealizedCurrencyExchangeGain" xlink:label="biol_DeferredTaxAssetsUnrealizedCurrencyExchangeGain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_DeferredTaxLiabilitiesCapitalizedIntangibleAssets" xlink:label="biol_DeferredTaxLiabilitiesCapitalizedIntangibleAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther"/>
<loc xlink:type="locator" xlink:href="biol-20121231.xsd#biol_DeferredTaxLiabilitiesStateTaxes" xlink:label="biol_DeferredTaxLiabilitiesStateTaxes"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="biol_DeferredTaxLiabilitiesCapitalizedIntangibleAssets" order="1.1500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="biol_DeferredTaxLiabilitiesStateTaxes" order="1.1600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="1.1700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsStateTaxes" order="1.0500" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="1.0600" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInventory" order="1.0700" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="1.0800" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOtherComprehensiveLoss" order="1.0900" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="biol_DeferredTaxAssetsUnrealizedCurrencyExchangeGain" order="1.1000" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1.1100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1.1400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1.1800" weight="-1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1.1200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.1300" weight="-1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfUnrecognizedTaxBenefits"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureFutureMinimumRentalCommitmentsUnderOperatingLeaseAgreements">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="1.0100" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="1.0200" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="1.0300" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="1.0400" weight="1.00" priority="2" use="optional"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="1.0500" weight="1.00" priority="2" use="optional"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfOptionActivity"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureOptionsOutstandingAndExercisable"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureCashProceedsAlongWithFairValueDisclosuresRelatedToGrantsExercisesAndVestingOptions"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSummaryOfNetRevenueByGeographicLocation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureConcentrationsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureNonRecurringEventAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/DisclosureConsolidatedValuationAndQualifyingAccountsAndReserves"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockPolicies"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSupplementalBalanceSheetDisclosuresTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsConcentrationsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsNonRecurringEvents"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"> </calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.biolase.com/taxonomy/role/NotesToFinancialStatementsScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockTables"> </calculationLink>
</linkbase>

Top
Filing Submission 0001193125-13-110112   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 5:59:23.1am ET